Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer

Abstract Background The benefits of continuing immunotherapy beyond disease progression in advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) remain uncertain, along with the specific patient subgroups that may gain the most from this approach. This retrospective study aim...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Cheng, Wenwen Kang, Yueying Chen, Luyun Pan, Hedong Han, Tangfeng Lv
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Cancer Immunology, Immunotherapy
Subjects:
Online Access:https://doi.org/10.1007/s00262-025-03958-9
Tags: Add Tag
No Tags, Be the first to tag this record!